Product
SARS-CoV-2 mRNA vaccine
Aliases
SARS-COV-2 mRNA vaccine, SARS-CoV-2 mRNA vaccine (RBMRNA-405)
Name
SARS-COV-2 mRNA vaccine
1 clinical trial
1 drug
1 indication
Indication
COVID-19Clinical trial
Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine (RBMRNA-405) as a Booster in Chinese Adults & OlderStatus: Completed, Estimated PCD: 2022-06-13